NCT00048529View on ClinicalTrials.gov

Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus

PHASE2SuspendedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2002

Conditions
Gastric CancerEsophageal Neoplasms
Interventions
DRUG

T900607-sodium intravenous

Trial Locations (5)

33612

Moffitt Cancer Center, Tampa

44106

Ireland Cancer Center, Cleveland

87131

University of New Mexico Cancer Research and Treatment Center, Albuquerque

92137

Scripps Health Center, San Diego

95032

Pacific Oncology Associates, Los Gatos

Sponsors

Lead Sponsor

Tularik
All Listed Sponsors
lead

Tularik

INDUSTRY

NCT00048529 - Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus | Biotech Hunter | Biotech Hunter